Reinbold, R., Hvinden, I., Rabe, P., Herold, R., Finch, A., Wood, J., . . . Schofield, C. (2022). Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Springer Nature.
Цитирование в стиле Чикаго (17-е изд.)Reinbold, R., et al. Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors. Springer Nature, 2022.
Цитирование MLA (9-е изд.)Reinbold, R., et al. Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors. Springer Nature, 2022.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.